Copyright
©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113896
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113896
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113896
Table 1 Proprotein convertase subtilisin/kexin type 9 levels in supernatants of primary liver cells and cell lines, mean ± SD
| Cells | LX-2 | HSC | PHH | Huh7 | HepG2 | HHSEC | KC |
| Number of cultures | 6 | 9 | 16 | 5 | |||
| Number of donors | 10 | 3 | 2 | ||||
| PCSK9 (ng/mL) | 6.8 ± 1.7 | 1.7 ± 1.5 | 2.4 ± 0.5 | 17.2 ± 6.9 | 27.0 ± 1.5 | 0.2 ± 0.1 | 0.1 ± 0.0 |
- Citation: Bundschuh J, Neumann M, Zimny S, Spirk M, Buechler C. Transforming growth factor beta reduces proprotein convertase subtilisin/kexin type 9 in the supernatant of hepatic stellate cells. World J Hepatol 2026; 18(1): 113896
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113896.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113896
